Benjamin Guigui, Nicolas Leveziel, Virginie Martinet, Nathalie Massamba, Margaret Sterkers, Gabriel Coscas, Eric H Souied ABSTRACT Aims Drusen are rarely observed in patients <50 years of age. Two types of early onset drusen (EOD) are commonly described: basal laminar drusen (BLD) and drusen associated with Malattia Leventinese (ML). Our purpose was to classify the phenotype of EOD on the basis of fundus examination, and fluorescein angiography (FA) and indocyanine green angiography (ICGA) features. Methods We performed a prospective study including 48 consecutive EOD patients. All of them had a complete ophthalmologic examination including FA and ICGA. Results BLD (67%) were extremely hyperfluorescent on FA and ICGA. ML (10%) was characterised by a combination of small radial and large round drusen with differences in staining in both FA and ICGA. We evidenced a third type of EOD (23%) harbouring an aspect of large colloid drusen (LCD), mildly hyperfluorescent in the early phases of FA, with a progressive staining in late phases. In intermediate and late phases of ICGA, LCD presented as hypofluorescent dot surrounded by a hyperfluorescent halo bordered by a thin hypofluorescent ring. Conclusion Three types of EOD are distinguished by their FA and ICGA features. We report a new kind of juvenile drusen, distinct from BLD and ML, named LCD, associated with a good vision and absence of complications.
INTRODUCTION
Drusen are extra cellular deposits that accumulate between the retinal pigment epithelium (RPE) and the inner collagenous layer of Bruch's membrane. 1 They are commonly considered as the initial pathological stage of age-related macular degeneration (AMD). 2 Drusen usually appear after the age of 50 years, but they are not only associated with AMD: they have also been observed earlier. The commonly described types of early onset drusen (EOD) are basal laminar drusen (BLD) and Malattia Leventinese (ML).
BLD were described in 1977 by Gass as small round yellow lesions randomly scattered in the macula and in the mid periphery of the retina. 3 Commonly appearing in the early adulthood, they are easily visualised by fluorescein angiography (FA), harbouring a typical 'stars in the sky' appearance in early phases. Vitelliform macular detachment is frequently associated with BLD. This type of EOD has also been related to membranoproliferative glomerulonephritis (MPGN) type II. 4 ML, also called dominant drusen, were described in 1925 by Vogt as a form of familial drusen with autosomal dominant inheritance, initially observed in patients living in the Leventine valley in the Ticino canton of southern Switzerland. This unusual inherited macular degeneration is caused by a mutation in the EGF containing fibrillin-like extracellular matrix protein 1 (EFEMP1) gene. 5 The diagnosis is based on fundus examination showing small radial drusen. 6 Our purpose was to analyse and classify phenotypes of EOD on the basis of FA and indocyanine green angiography (ICGA) features.
METHODS
A prospective study was undertaken between 2006 and 2009 at the Creteil University Eye Clinic, France. A complete ophthalmologic examination was performed for all patients including best corrected visual acuity (BCVA), fundus examination, colour fundus photographs, red free, infrared, fundus autofluorescence frames (Heidelberg Retina Angiograph; Heidelberg Engineering, Heidelberg, Germany), FA (Zeiss FF450IR, Carl Zeiss Inc., San Leandro, CA, USA or HRA, Heidelberg Engineering, Heidelberg, Germany), and infrared and confocal ICGA (HRA, Heidelberg Engineering).
Criteria for inclusion were presence of drusen on fundus examination diagnosed before the age of 50 years old. Criteria for exclusion were age-related macular degeneration (AMD), Stargardt disease, vitelliform macular dystrophy, severe diabetic retinopathy, and media opacities that would not allow a precise examination of the retina. Diagnostic criteria for BLD were based on fundus examination and FA ('stars in the sky' pattern). Diagnostic criteria for ML were mainly based on fundus examination (small radial drusen associated with large and round drusen located around the optic nerve in the macular area).
RESULTS
A total of 96 eyes of 48 patients (33 women and 15 men) were included in this prospective study. Mean age at presentation was 45.3 years old and mean age at diagnosis was 38 years old (table 1) . Mean BCVA was 20/32 (ranging from 20/20 to 20/2000).
BLD were observed in 32/48 patients (67%, 20 women and 12 men; table 2). Mean age at diagnosis of BLD, based on medical questionnaire or previous medical examination, was 40 years old (ranging from 18 to 50 years old). Mean age at inclusion was 49 years old. Mean BCVA was 20/40 (ranging from 20/20 to 20/2000). Three of 32 patients with BLD had MPGN type II. Fundus examination and colour fundus photographs showed numerous variable sized small yellow-white subretinal deposits located in the macula and the peripheral retina ( figure 1A) . In 30/64 eyes (47%), BLD were arranged with clustered groups scattered throughout the retina. In 18/64 eyes (28%), an area without drusen figure 1B ). In the early phases of FA, drusen are easily visualised as intense hyperfluorescent spots. A typical 'stars in the sky' pattern was observed in all cases ( figure 1C) . In late phases, fluorescence decreased slowly. In the early phases of confocal ICGA, BLD were faintly visualised as hyperfluorescent spots. In the middle and late phases, BLD appeared hyperfluorescent and confluent. However, some drusen appeared hypofluorescent in the late phases of ICG (figure 1F). ML was diagnosed in 5/48 patients (10%, four women and one man; table 1). Two patients were sisters. All patients had autosomal dominant inheritance. Mean age at diagnosis was 32 years old and mean age at inclusion was 34 years old (ranging from 27 to 44 years old). Mean BCVA was 20/50 (ranging from 20/25 to 20/200). In 2/10 eyes (20%) of two patients, the poor visual acuity was explained by a central chorioretinal atrophy. Colour fundus photographs showed whitish drusen of different size associated with pigmentary changes (atrophy, pigment migration and hyperplasia). The largest drusen were round, confluent, and localised around the macula and the optic disc. The smallest drusen, with a characteristic radial distribution, were mostly localised temporally to the macular area (figure 2). In red free frames, the bright round drusen were easily distinguished from the small radial drusen. AF frames revealed an intense autofluorescence of large drusen, whereas small drusen were faintly visible ( figure 2B ). In the early phases of FA, large central drusen were hypofluorescent and small peripheral radial drusen were highly hyperfluorescent ( figure 2C ). In the late phases of FA, fluorescence of large drusen increased, harbouring a fuzzy aspect. They surrounded a central hypofluorescent area, corresponding to a relative central sparing ( figure 2D) . Conversely, hyperfluorescence of small radial drusen decreased in the late phases of FA. No CNV was observed. In the early phases of ICGA, large drusen were hypofluorescent and small peripheral radial drusen were hyperfluorescent. In the late phases of ICGA, large drusen presented as hyperfluorescent spots surrounded by a hypofluorescent halo in all eyes, whereas small drusen were mildly hyperfluorescent or not clearly seen ( figure 2F) .
All the remaining patients (11/48; 23%; nine women and two men) presented similar angiographic features of their EOD (table 1) . No medical history or familial retinal disease was noted. Mean age was 35 years old at diagnosis and 40 years old at presentation (ranging from 26 to 53 years old). Mean BCVA was 20/25 (ranging from 20/20 to 20/40). Colour fundus photographs showed an aspect of large colloid drusen (LCD). Size of drusen was about 200 to 300 mm (figure 3). No pigmentary changes or vitelliform macular detachment was observed. In 6/22 eyes (27%) of three patients, these LCD were preferentially concentrated on the temporal perifoveolar region; in 4/22 eyes (18%) of two patients, they were preferentially concentrated on the macular region; and in the remaining 12/22 eyes, they were evenly distributed on the posterior pole of the retina. In 10/22 eyes (45%), these LCD were confluent. Some small drusen could be associated and were more peripheral. In red free frames, large bright round drusen were easily distinguished and surrounded by a thin dark ring ( figure 3B ). AF frames revealed autofluorescence of the LCD ( figure 3E ). In the early phases of FA, LCD were mildly hyperfluorescent. Their hyperfluorescence was not homogenous and began in the middle periphery of the drusen, sparing a small dark centre and a peripheral thin hypofluorescent ring ( figure 3C ). During the sequence, fluorescence of the drusen increased and in the late phases of FA, drusen were homogenously hyperfluorescent ( figure 3D ). No leakage was observed. No CNV or atrophy was noted in the 22 eyes. The small drusen, inconstantly associated with LCD, were hyperfluorescent during all the sequence. In the early phases of ICGA these LCD were hypofluorescent in all patients (figure 3F). In 2/22 eyes (9%) some drusen were also isofluorescent. In the intermediary phases of ICGA most of drusen were hypofluorescent. In the late phases of ICGA a different pattern of staining was observed and different features of LCD could be detected in a same eye ( figure 3G,H) . In 4/22 eyes (18%) they were mainly hyperfluorescent and in 18/22 eyes (82%) they were mainly hypofluorescent. However, hypofluorescent drusen were not homogeneous in the intermediary and late phases, appearing as a small dark centre surrounded by a discreetly more fluorescent large halo, bordered by a peripheral thin hypofluorescent dark annulus ( figure 3 ). This unusual feature was observed in all eyes. Furthermore, some hyperfluorescent pinpoints were noted in 12/22 eyes (55%).
DISCUSSION
In our study, our purpose was to analyse and classify the different types of EOD on the basis of their clinical and angiographic characteristics.
In our series, drusen were more commonly observed in women than in men (ratio 2/1) as described in previous series of patients with BLD. 7 8 BLD were the most frequent type of drusen observed in young people (67%) and ML accounted for 10% of patients (table 2). It is notable that the remaining EOD patients (23%) shared similar angiographic features, distinct from BLD and ML. We name them LCD throughout this manuscript. Patients with BLD or LCD had no familial retinal history, while all patients suffering from ML had a parent affected. Mean visual acuity was better in LCD eyes (20/25) than BLD eyes (20/40) or ML eyes (20/50), although the difference was not significant, probably because of a lack of power related to a relatively small number of patients in each subgroup. The better visual acuity in the group of LCD could be explained by the younger age and the lack of follow-up. Moreover, LCD were not associated with atrophy or CNV in our series, as sometimes observed in ML or BLD. Our observational study was not designed to analyse the progression of LCD. It remains possible that long-term complications such as retinal pigment atrophy and visual loss could be observed with a longterm follow-up. Patients affected with BLD were significantly older than patients affected with ML (p¼0.02) and than patients affected with LCD (not significant; p>0.05). In our series, BLD were complicated by CNV in 10% eyes. In other studies, the occurrence of CNV secondary to BLD varies from 4% to 36%.
However, we are aware that the lack of follow-up could be a limitation of our study. It is possible that LCD are complicated by atrophy or CNV in a longer follow-up period.
The main findings of our study are ICGA features showing three distinct patterns. Two types of BLD are distinguished with ICG (hyperfluorescent drusen with some hypofluorescent drusen). Moreover, vitelliform macular detachment observed in 48% of our BLD patients is also easily differentiated from CNV by ICG. 10 Vitelliform macular detachment appears progressively and can be associated with poor visual outcome when it changes to a geographical atrophy. In ML, ICGA differentiates two types of drusen.
11 in late phases of ICGA, large drusen of ML appear as hyperfluorescent spots surrounded by halos of hypofluorescence. The significance of this peculiar 'pustuliform-like' feature in ML is not clear. It could be explained by the physical or substructural characteristics of the drusen. In LCD, the drusen appear in intermediary and late phases of ICGA like a hypofluorescent centre surrounded by a hyperfluorescent halo. This halo is bordered with a peripheral thin hypofluorescent ring, harbouring a 'donut shape' (figure 3). This unusual feature appears as the opposite image of ICGA features of large drusen of ML. This 'donut-shape' can also be distinguished on infrared frames and in early phases of FA. In age-related soft drusen, an original autofluorescence pattern characterised by a central area of decreased autofluorescence surrounded by an annulus of increased autofluorescence has been described, suggesting changes in retinal pigment epithelium. 12 The difference in lipid composition between the core and the edge of the drusen could be responsible for these patterns of staining. Several studies have shown that AMD drusen possess a central distinct structural core domain, surrounded by a cholesteryl ester shell. 13 14 A core-like structure was also described for BLD. 15 16 Thus, a difference in the fluorescence between the centre and the periphery in a drusen could also be explained by structural differences. Other examinations, such as high-definition spectral-domain optical coherence tomography or adaptative optics, could be useful to analyse these unusual features and to explain structural differences. Further studies are needed to analyse and compare spectraldomain optical coherence tomography features in EOD. This is a phenotypic report. Another limit of the study is the lack of genetic testing in our series. No genotypic study or molecular analysis was done. Here, we observed three types of EOD, but there are probably other types of drusen. Several macular diseases have been described in young people and our findings could be helpful to establish a continuum. A strong association between AMD and the Tyr402His variant of the complement factor H gene (CFH) has been established. 17 This polymorphism is also associated with BLD 18 19 and with MPGN type II. 20 In both diseases, a basal activation of the alternative pathway of the complement cascade leads to immune deposits in the lamina densa of the glomerular basement membrane (MPGN type II) or in Bruch's membrane (BLD). X-linked Alport syndrome is characterised by a central and peripheral dot-andfleck retinopathy associated with renal failure. It can look like BLD and a retinal 'lozenge' or 'dull macular reflex' has been described in some patients. The pathogenesis of the retinal dots and flecks is independent of CFH-dependent mechanisms and may depend on the nature of the underlying COL4A5 mutations. 21 On the other hand, the Arg345Trp mutation of the EFEMPI gene is associated with ML and to Doyne honeycomb retinal dystrophy. 5 This gene encodes fibuline 3, an extracellular matrix protein. 22 An abnormal accumulation of the Arg345Trp variant of EFEMP1 in RPE cells and in Bruch's membrane may cause drusen formation. 23 Most young adults with drusen associated with chromosome 6 have fine macular drusen and good vision, whereas affected infants and children may have congenital atrophic maculopathy. In a family with autosomal dominant drusen and atrophic macular degeneration, the gene maps on chromosome 6q14. This locus is distinct from, but adjacent to, the loci for cone-rod dystrophy 7 (CORD7) and North Carolina macular dystrophy (MCDR1). 24 Sorsby fundus dystrophy is a rare autosomal dominant early onset maculopathy. Drusen and atrophy or metaplasia of the retinal pigment epithelium can be observed. Furthermore, CNV can occur. An extensive macular atrophy with pseudodrusen occurring in the middle-aged adult has been recently described. 25 Further studies are needed to investigate the genetics of LCD.
In conclusion, in this study we describe a third type of EOD, harbouring particular features on FA and ICG, distinct from BLD and ML features. This third type, called LCD, accounts for 23% of EOD and seems to be associated to good visual outcomes. FA and ICG features are useful in distinguishing the three subtypes of EOD (table 2) .
